Abstract. Without using sperm, artificial oocyte activation is essential for current assisted reproductive technologies, particularly somatic cell nuclear transfer and round spermatid injection. Strontium has been widely used as an activator of oocytes especially in the mouse, by which efficient oocyte activation requires Ca 2+ -free medium. In this study, we examined whether Sr 2+ can efficiently activate oocytes in Ca 2+ -containing culture media when calcium is chelated. Ethylene glycol-bis (β-aminoethyl ether) -N, N, N', N'-tetraacetic acid (EGTA) was added to three standard culture media (CZB, M16 and KSOM) for mouse embryos because it preferentially binds Ca 2+ rather than Sr 2+ . We found that treatment with 5 mM Sr 2+ and 2 mM EGTA left fewer than 1% of oocytes at the MII stage, which is comparable to that of Ca 2+ -free medium. As a result, addition of 2 mM EGTA along with 5 mM Sr 2+ in either CZB, M16 or KSOM made more than 80% of available activated oocytes, which was comparable to or better than 72% in a Ca 2+ -free Sr 2+ medium, since EGTA-Sr 2+ activation led to significantly less oocyte degeneration than Ca 2+ -free Sr 2+ activation. Furthermore, we demonstrated that this activation method can support the birth of cloned embryos. Thus, addition of EGTA to typical Ca 2+ -containing culture media can easily produce activation media that does not interfere with embryonic development.
Abstract. Without using sperm, artificial oocyte activation is essential for current assisted reproductive technologies, particularly somatic cell nuclear transfer and round spermatid injection. Strontium has been widely used as an activator of oocytes especially in the mouse, by which efficient oocyte activation requires Ca 2+ -free medium. In this study, we examined whether Sr 2+ can efficiently activate oocytes in Ca 2+ -containing culture media when calcium is chelated. Ethylene glycol-bis (β-aminoethyl ether) -N, N, N', N'-tetraacetic acid (EGTA) was added to three standard culture media (CZB, M16 and KSOM) for mouse embryos because it preferentially binds Ca 2+ rather than Sr 2+ . We found that treatment with 5 mM Sr 2+ and 2 mM EGTA left fewer than 1% of oocytes at the MII stage, which is comparable to that of Ca 2+ -free medium. As a result, addition of 2 mM EGTA along with 5 mM Sr 2+ in either CZB, M16 or KSOM made more than 80% of available activated oocytes, which was comparable to or better than 72% in a Ca 2+ -free Sr 2+ medium, since EGTA-Sr 2+ activation led to significantly less oocyte degeneration than Ca 2+ -free Sr 2+ activation. Furthermore, we demonstrated that this activation method can support the birth of cloned embryos. Thus, addition of EGTA to typical Ca 2+ -containing culture media can easily produce activation media that does not interfere with embryonic development. he ovulated mammalian oocyte remains arrested at the second meiotic metaphase stage until sperm induce meiotic resumption by a series of Ca 2+ oscillations at fertilization [1] . This sperminduced calcium oscillation is mediated by the inositol triphosphate (Insp3) receptors [2, 3] . Activation events led by these oscillations include cortical granule release, completion of meiosis with the extrusion of the second polar body, and pronuclear formation. Studies regarding artificial activation enhance understanding of the mechanism of fertilization and cell signaling. Furthermore, without using sperm, artificial oocyte activation is essential for the current assisted reproductive technologies, particularly somatic cell nuclear transfer and round spermatid injection (ROSI) [4, 5] .
To date, many artificial activation methods, including ethanol, electrical stimulation and calcium ionophore, have been developed [6] . However, most parthenogenetic agents cause a monotonic increase in Ca 2+ . On the other hand, Sr 2+ -containing medium induces repetitive intracellular Ca 2+ oscillations similar to those that occur during normal fertilization [7, 8] . Thus, the method of activation by Sr 2+ is assumed to resemble that following normal fertilization even if it does not completely mimic that induced by sperm [9, 10] . Nowadays, Sr 2+ -induced oocyte activation is widely used to achieve full-term development after round spermatid injection (ROSI) [11, 12] and somatic cell nuclear transfer [4, 13] , especially in mice. Recent studies demonstrate Sr 2+ -induced activation is also applicable in mammals other than mouse [14] [15] [16] [17] [18] . Sr 2+ -induced oocyte activation has been known for a long time [19, 20] but the molecular mechanism of oocyte activation by Sr 2+ has not been well elucidated. Recent studies indicate Sr 2+ can release stored calcium in a couple of ways, such as stimulation of adenylyl cyclase type VIII [21] and Ca 2+ -dependent Ca 2+ release [10] . Importantly, this efficient Sr 2+ -induced activation requires Ca 2+ -free medium [19, 20] . However, if the interference of Sr 2+ -induced oocyte activation by Ca 2+ is simply dependent on the amount of Ca 2+ in the media, chelating Ca 2+ may enhance Sr 2+ -induced oocyte activation even in the presence of calcium.
In the present study, we examined whether addition of ethylene glycol-bis (β-aminoethyl ether) -N, N, N', N'-tetraacetic acid (EGTA), a membraneimpermeable Ca 2+ chelator [22] , into normal Ca 2+ -containing culture media can enhance Sr 2+ -induced oocyte activation.
Materials and Methods

Animals
B6D2F1 mice (C57BL/6 × DBA/2) were used to prepare oocyte and somatic-cell (cumulus cell) donors. Surrogate females were ICR females mated with vasectomized males of the same strain. All animals obtained from SLC (Shizuoka, Japan) were maintained in accordance with the Animal Experiment Hand Book at the Center for Developmental Biology (RIKEN).
Collection of oocytes and embryo culture
Mature oocytes were collected from the oviducts of 8-12-week-old females that had been induced to superovulate with 5 IU pregnant mare serum gonadotropin (PMSG) followed by 5 IU human chorionic gonadotropin (hCG) 48 h later. Oocytes were collected approximately 16 h after hCG injection, placed in HEPES-buffered CZB medium, and treated with 0.1% hyaluronidase until the cumulus cells dispersed. The oocytes were then placed in modified CZB (mCZB), which consisted of CZB [23] supplemented with 5.55 mM D(+)Glucose, KSOM (MR-020P; Specialty Media, Phillipsburg, NJ, USA) or M16 (M7292; Sigma-Aldrich Chemical, St. Louis, MO, USA) covered with mineral oil (M8410; Sigma) and stored at 37 C (5% CO 2 /air).
Oocyte activation by Sr 2+ with EGTA
The EGTA tetrasodium salt [ethylene glycol-bis (β-aminoethyl ether) -N, N, N', N'-tetraacetic acid tetrasodium salt; E8145; Sigma] was dissolved in distilled water to produce a 0.5 M stock solution (stored at 4 C). EGTA stock solution was added to the media (mCZB, M16 or KSOM) to obtain the desired final concentrations (0.2 to 10 mM EGTA in this study) when the appropriate amount of SrCl2 (Strontium Chloride Hexahydrate; 193-04182; Wako) was added using a 100 mM stock solution dissolved in distilled water (stored at room temperature). Oocytes were incubated for at least 20 min after collection in the same media as that which will be used for activation. Parthenogenetic activation was induced by 5 mM SrCl 2 in either Ca 2+ -free mCZB or any media with EGTA, and oocyte activation was examined using an inverted microscope with a Relief Contrast condenser (IX71; Olympus, Tokyo, Japan). To evaluate the effect of EGTA on the efficiency of Sr
2+
-induced oocyte activation, we classified Sr 2+ -treated oocytes into the following four categories: 1) activated oocytes, which were oocytes with one pronucleus and a second polar body (1PN+1PB), 2) abnormal oocytes including oocytes with two pronuclei and fragmented oocytes, 3) dead oocytes and 4) MII oocytes. The ratios were calculated by dividing the number of oocytes belonging to each category by the total number of the Sr2+-treated oocytes. For each concentration of EGTA, at least twenty oocytes were examined with three repetitions.
Production of parthenogenetic diploid embryos
For production of diploid parthenogenetic embryos, mature oocytes were activated by 5 mM SrCl 2 in 2 mM EGTA-containing or Ca 2+ -free mCZB medium in the presence of 5 µg/ml cytochalasin B for 6 h and cultured at 37 C under 5% CO 2 in air up to for 4 days (96 h) in Ca 2+ -included mCZB medium [4, 24] . SR
Production of cloned embryos
Nuclear transfer was performed as described previously [4] , except for treatment with trichostatin A treatment (TSA) [25] [26] [27] . Briefly, enucleated B6D2F1 oocytes were injected individually with cumulus cells from the same B6D2F1 strain. After nuclear transfer, the reconstructed oocytes were activated for 6 h by 5 mM SrCl 2 in the presence of 5 µg/ml cytochalasin B and 5 nM TSA (T8552; Sigma). Then, these activated oocytes were washed and placed in KSOM media with 5 nM TSA for another 4 h. Subsequently, these oocytes were cultured without TSA until the time of embryo transfer.
Statistical analyses
The data were compared using chi-square test analysis with Yates correction for continuity. A value of P<0.01 was considered to be statistically significant.
Results
Oocyte activation with Sr 2+ depends on the concentration on EGTA
When cumulus-free mouse oocytes were treated with 5 mM SrCl 2 in mCZB, 6 h treatment resulted in only around 0-25% of oocyte activation. These activation rates, however, were not significantly different from those without SrCl 2 (data not shown), suggesting these activations spontaneously occurred independent of Sr 2+ . The remaining oocytes were still held at the MII stage (Fig. 1A) . In contrast, treatment with 5 mM SrCl 2 in Ca 2+ -free mCZB led to an average activation rate of 72%. In this medium, none of the other oocytes remained as MII oocytes, but they did exhibit a high amount of Sr 2+ -induced oocyte degeneration rate, 28% (Fig.  1F) . Thus, Ca 2+ -free medium was essential for efficient oocyte activation with Sr 2+ , as previously reported [20] . Next, the Sr 2+ treatment in mCZB was performed in the presence of EGTA, a calcium chelator, of which concentrations increased from 0 to 10 mM EGTA. The activation rates increased only with addition of 1 to 5 mM EGTA (Fig. 1B- without EGTA in mCZB; however almost no activated oocytes were found. After addition of a final concentration of EGTA between 1-5 mM, the number of activated oocytes (asterisk), as defined as oocytes with one pronucleus and a second polar body, significantly increased (B-D). Prominently, 2 mM EGTA resulted in the maximum activation rate (C). In contrast, after activation with 5 mM EGTA or more (10 mM), the activation rate decreased (D, E). After 6 h activation with 10 mM EGTA, swelling oocytes were often found without any pronuclei (arrow head). Ca 2+ -free Sr 2+ activation, as a control, showed a high rate of oocyte activation; however significant oocyte degeneration (arrow) was observed that led to a decreased net number of activated oocytes (F). In each panel, abnormal oocytes, including oocytes with two pronuclei and fragmented oocytes, are denoted by white arrows. ment with either Ca 2+ -free Sr 2+ or Sr 2+ with 2 mM EGTA led to 100% or 97% oocyte activation, respectively, in terms of the number of surviving oocytes, the net number of activated oocytes following Sr 2+ treatment with 2 mM EGTA would be significantly higher than that of the Ca 2+ -free Sr 2+ treatment because of less oocyte degeneration.
Oocyte activation profiles along with EGTA concentrations in M16 and KSOM media
Since many Ca 2+ -free media (e.g., Ca 2+ -free M16 and α-MEM as well as CZB) can be used for oocyte activation [4, 6, 28] , it is important to confirm the general effect of EGTA. Therefore, addition of EGTA into M16 and KSOM was examined to determine the efficiency of oocyte activation by Sr
2+
. As a result, the effects of EGTA were confirmed. Addition of 2 mM EGTA resulted in activation rates of 99% or 82% in M16 or KSOM, respectively, and these activation rates were the most efficient ( Fig.  2A and B) 
Overdose of EGTA prevents oocyte activation
As observed above, only 1-5 mM EGTA led to significant oocyte activation. For example, 5 mM Sr 2+ with 10 mM EGTA activated less than 10% of oocytes ( Figs. 1 and 2 ). Why do higher concentrations of EGTA prevent oocyte activation? One possibility is that higher concentrations of EGTA chelate Sr 2+ in addition to chelating Ca 2+ , thereby preventing activation. To confirm this possibility, we examined whether increasing Sr 2+ can resume the efficient oocyte activation while including 10 mM EGTA. As a result, 10 mM Sr 2+ activated 93% of oocytes even with 10 mM EGTA (Fig. 3A) . Thus, 10 mM EGTA seems to be enough to chelate both 1.7 mM Ca 2+ and 5 mM Sr 2+ . We also found that 10 mM EGTA increased the pH of the media by 0.2 ( Fig. 3B) (Fig. 3B) . Thus, the concentration of EGTA should be optimized based on the concentrations of Ca 2+ and Sr 2+ .
Embryonic development following oocyte activation with EGTA
EGTA has been used in culture media; however, less than less than 1 mM is used in most cases [29, 30]. We examined whether oocyte activations with EGTA affects subsequent embryonic development. First, parthenogenetic diploid embryos were made under cytochalasin B (CCB), which prevents second polar body extrusion and results in diploid parthenogenetic embryos. After activation with 2 mM EGTA and CCB, more than 90% of the oocytes were observed as activated oocytes, which was significantly higher than that after activation in Sr 2+ medium ( Table 2 ). This was because of less oocyte degeneration when using EGTA (Table 2) . Culturing for 96 h after activation, no significant difference was observed in blastocyst formation among the surviving activated embryos between then EGTA and Ca 2+ -free experimental groups (Fig.  4A and Table 2 ). However, because of less oocyte degeneration, the number of final available blastocysts produced by EGTA-Sr 2+ activation was significantly higher than that by Ca 2+ -free Sr 2+ activation (Table 2) . Second, we applied this EGTA activation method to clone mice from cumulus cells. Following the recent TSA cloning method [25] , 2-cell cloned embryos were transferred into surrogate mothers. As a result, cloned embryos were obtained with a success rate of 4%, and the resulting pups were weaned normally ( Fig. 4B and Table 3 ). Thus, the EGTA-Sr 2+ activation method was demonstrated to be on par with the Ca 2+ -free Sr 2+ activation method in terms of the activation efficiency and embryonic development.
Discussion
In this study, we examined whether chelating the Ca 2+ in normal Ca 2+ -containing culture medium using EGTA can enhance oocyte activation by Sr 2+ instead of using Ca 2+ -free media. We subsequently found that the addition of EGTA dramatically increased the efficiency of Sr 2+ -induced oocyte activation in three standard culture media, mCZB [23] , M16 [31] and KSOM [32] , but only a narrow range of EGTA concentrations, such as 1-5 mM, could be used for efficient oocyte activation. Specifically, 2 mM EGTA led to maximum activation rates in all three different media. We also found that EGTA activation resulted in significantly less oocyte degeneration than during Ca 2+ -free activation. Furthermore, we demonstrated that activation under EGTA could support full-term development after somatic cell nuclear transfer. Therefore, this transformation method consisting of addition of EGTA to normal culture medium to create oocyte activation medium should minimize effort and cost in preparation of another medium, that is, Ca 2+ -free medium, for oocyte activation in addition to preparation of a standard culture medium. Furthermore, it shows that any commercial CZB, KSOM or M16 media can be easily used for oocyte activation. Ca 2+ -free medium is essential to efficiently activate the oocyte by Sr 2+ [20] . Our results show that the effect of chelating Ca 2+ is equivalent to that of the Ca 2+ -free media in terms of enhancement of oocyte activation and indicate that once the [Ca (EGTA)] 2-complex forms, Ca 2+ cannot interfere with Sr 2+ -induced oocyte activation anymore. This enhancement is strongly dependent on the concentration of EGTA, such as 1-5 mM, which is at least 10-times higher than previously used [29, 30] . Furthermore, EGTA is known to have an embryo-toxic effect [33] . Therefore, it was important to address whether or not exposure of embryos to this complex during the activation period (6 h in this study) interferes with progressive embryonic development. As a result, we demonstrated that using Sr 2+ -induced activation with 1-2 mM EGTA allowed us to successfully clone mice by somatic cell nuclear transfer, indicating the presence of EGTA during oocyte activation does not disrupt continued embryonic development.
Again, only a minimal range of EGTA concentrations, such as 1-5 mM, for 5 mM Sr 2+ allows significant activation of oocytes. Neither higher nor lower concentrations than within the range of EGTA show any significant promotion of oocyte activation. This fact could explain failure of previous similar attempts using 0.1 mM EGTA [29] . Failure of activation at lower concentrations could be explained by insufficient chelating. That is, when using less than 1mM EGTA, more than half of the Ca 2+ is not chelated, which prevents Sr 2+ -induced oocyte activation since the media tested contains 1. [34] , indicating that EDTA binds to these ions with less specificity. As a result, the optimal concentration of EDTA for oocyte activation may be more limited than that of EGTA. Ideally, the best chelator for oocyte activation would be membrane-impermeable that specifically binds to Ca 2+ , but neither Sr 2+ nor Mg 2+ , with less toxicity.
In our study, 2 mM EGTA including 5 mM SrCl 2 resulted in the best activation rates in all three standard media tested: mCZB, M16 and KSOM. This result is consistent with the fact that these media commonly contain 1.7 mM CaCl2 regardless of the different concentrations of ions in the other chemical components (Table 1) . Therefore, in any other media, the best concentration of EGTA to be added for oocyte activation would probably be around or just above the same concentration of calcium contained in the medium. On the other hand, we found that 10 mM EGTA including 10 mM SrCl 2 also resulted in activation of more than 90% of the oocytes (Fig. 3A) , suggesting that a wider range of EGTA can be used with 10 mM SrCl2. Therefore, the proper concentration of EGTA may also change depending on the concentration of SrCl 2 . However, in regard to the potential toxicity of EGTA, it is wise to optimize for the highest Sr 2+ -activation rate using the lowest concentration of EGTA with the best embryonic developmental rate.
In summary, chelating Ca 2+ provides a simple and low-cost method to transform normal Ca 2+ -containing culture media into "Ca 2+ -free" activation medium as long as the proper concentration of chelator is used. Nowadays, most media have become commercially available, but obtaining Ca 2+ -free media usually requires manual preparation or an expensive custom order, even though this Ca 2+ -free media is normally used in mouse cloning and ROSI. Therefore, our method should be helpful in all laboratories working in this reproductive technology field.
